|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Pharmaceutical Development Services 
|
|
PDS provides pharmaceutical development, regulatory affairs, eCTD solutions / electronic publishing, quality systems, pharmacovigilance, interim management, and training consultancy to pharmaceutical and biotechnology companies. Compliance and due diligence audits are performed on behalf of clients, together with project management services.
Activity:
- Clinical Trials
- Contract Manufacturing
- Manufacturing
- Regulatory Affairs & Legal Services
- Research & Development
Product / Technology type(s) covered:
- API / chemicals
- Bio
- Devices
- Drug delivery
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
- Technology
Therapeutic targets:
- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Gastrointestinal
- Geriatrics
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Pain
- Pediatrics
- Reproductive Health
- Respiratory Medicine
- Stroke
- Urology
- Women's Health
|
|
Company Contact
|
Pharmaceutical Development Services
Surrey Technology Centre
GU2 7YG Guildford
United Kingdom
Phone: +44 1483 685420
FAX: +44 1483 685421
Website: http://pharmdservices.com
Send an email
|
|
Markets Covered
a. HeadQuarter: United Kingdom
b. Continent(s) active:
Europe
, Far East
, North America
c. Countries active: All
Corporate data:
Number of Employees: 8
Turnover:
| Amount: |
Year: |
Currency: |
| 800,000 |
2006 |
Euro |
Year founded: 2000
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: 27-Nov-2008.
|